Jenny Shun Wah Lee

Jenny Shun Wah Lee

Auto-generated profile, based on publicly available information

Jenny Shun Wah Lee

Jockey Club Institute of Aging, The Chinese University of Hong Kong, Hong Kong

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2026 in Heart, Lung and Circulation
Verified
Journal Article
Open access
TATung Wai Auyeung
Tung Wai Auyeung
JLJenny Shun Wah Lee
Jenny Shun Wah Lee
Erik FungErik Fung
Erik Fung
JLJason Leung
Jason Leung
TKTimothy Kwok
Timothy Kwok
Jean WooJean Woo
Jean Woo
This community-based cohort study aimed to examine whether baseline heart diseases predict incident frailty over 20 years. A total of 3,998 non-frail adults (2,000 men, 1,998 women) aged ≥65 years were included at study entry. Heart disease was defined as self-reported, medication-verified chronic heart failure, myocardial infarction, or angina pectoris. Frailty was assessed at interval using the FRAIL scale (score ≥3 defining frailty) at baseline and was repeated at: 2-years, 4-years, 14-years, 18-years and finally 20-years follow-up. Cox proportional hazards models, stratified by sex and adjusted for age, diabetes, hypertension, smoking, and BMI, analysed the association between heart disease and time to incident frailty. At baseline, heart disease prevalence was 18.3% in men and 16.5% in women. Over a total follow-up duration of 62,012 person-years, baseline heart disease was demonstrated to be a significant independent predictor of frailty after adjustment for confounders. The risk was greater in men (adjusted hazard ratio [aHR] 1.77, 95% confidence interval [CI]: 1.26-2.48, p 0.001) than in women (aHR 1.34, 95% CI: 1.00 - 1.80; p=0.048) CONCLUSIONS: Heart diseases, apart from being a primary driver of mortality, are significant independent predictors of incident frailty in older adults, with a stronger effect observed in men. This highlights the need for frailty screening and preventive strategies in older patients with heart disease.

3 November 2026 in European Heart Journal Open
Verified
Journal Article
Open access
KNKwan Hung Ng
Kwan Hung Ng
GLGloria H W Lau
Gloria H W Lau
PCPik Sui Briony Chan
Pik Sui Briony Chan
KYKa Man Yu
Ka Man Yu
JLJenny S W Lee
Jenny S W Lee
Erik FungErik Fung
Erik Fung
Aims: Available atherosclerotic cardiovascular disease (ASCVD) risk calculators predict acute events suboptimally in the elderly. We aimed to determine if DNA methylation (epigenetic) age acceleration (EAA) was associated with atherogenic inflammageing and predictive of adverse outcomes incremental to SCORE2-OP and PREVENT. Methods and results: Participants stratified using the FRAIL scale (robust/pre-frail/frail) were randomly selected in approximately equal proportions from a parent cohort of 1400 community-living older adults. Five epigenetic clocks were developed from MethylationEPIC-analysed blood DNA to calculate baseline EAA by regressing chronological age on epigenetic age. Proton-nuclear magnetic resonance was used to profile serum lipoproteins/lipids and glycosylated acetyls. The primary outcome was a composite endpoint of incident all-cause mortality, cardiovascular hospitalization (CVH), and ASCVD/acute coronary syndrome hospitalization (AAH). Time-to-event analyses were performed. Among epigenetic clocks analysed in 535 individuals aged 60–99 years, GrimAge2 EAA (Grim2AA) was most significantly associated with cardiometabolic comorbidities and atherogenic inflammageing. During follow-up of 4.6 years, 30 were lost to follow-up, whereas 42 experienced AAH. Cox regression determined that Grim2AA was predictive of CVH (P < 0.05) and AAH (P < 0.01) but not all-cause mortality. For every 1-year increase in Grim2AA, the hazards of CVH and AAH were significantly increased by 6% and 11%, respectively. The predictive performance of AAH by SCORE2-OP and PREVENT was improved by Grim2AA: concordance index 0.693–0.734 (P < 0.05) and 0.682–0.725 (P < 0.01), respectively. In Kaplan–Meier analysis, the probability of AAH was significantly higher in individuals with Grim2AA ≥ 0 (acceleration or none) than <0 (deceleration) (P < 0.01). Conclusion: Grim2AA may independently predict AAH incremental to SCORE2-OP and PREVENT in older adults.